Discover
Science Will Win

Science Will Win
Author: Pfizer
Subscribed: 90,297Played: 197,261Subscribe
Share
© 2026 Pfizer Inc.
Description
Science Will Win is a podcast that takes listeners under the microscope on some of the most promising medical innovations, exploring therapies that have the potential to shape the future of healthcare and offer new hope to patients around the world. Through conversations with a diverse line-up of guests, including scientists and experts, patient advocates, and, most importantly, patients themselves, each miniseries will focus on a unique healthcare challenge, diving into the fascinating science, policy challenges, and potential to transform patients’ lives for the better.
This podcast is powered by Pfizer.
This podcast is powered by Pfizer.
39 Episodes
Reverse
Many people still believe that weight is simply a matter of willpower. Eat less, move more, right? But the reality is far more complicated, and we still have plenty to learn about the hidden biological forces driving the numbers on the scale. This week, we’re diving into the complex biological networks that underpin obesity. How do genetics and brain chemistry influence our appetite? How do hormones shape where our bodies store fat and help dictate comorbidity risk? And how can understanding these individual biological differences guide us toward a more personalized future for obesity care? Featured guests: – Dr. Manige Konig, Vice President and Obesity Franchise Development Head, Pfizer – Dr. Giles Yeo, Professor of Molecular Neuroendocrinology, University of Cambridge Dive into the episode here: 00:00 – Why weight isn’t a choice 03:50 – The genetics of body weight and appetite 14:26 – How fat distribution and hormones impact health risks 22:49 – The future of personalized obesity care Check out our YouTube channel (@Pfizer) to watch full interviews with Joe & special experts and guests for more on obesity. Season 7 of Science Will Win is created by Pfizer and hosted by Dr. Joe Hanson. It’s produced by Acast Creative Studios. Hosts in this podcast series were compensated for their time. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
For decades, BMI has been the most widely used tool for measuring obesity. But recently, the medical community has begun to move away from using it as the main way to measure and define obesity. So in this episode, we’re opening up a nuanced discussion about why this popular tool… was never really built for the job. Why do we still use BMI? What are its limitations? And is there a better way to understand and measure obesity? Host Joe Hanson dives in. Featured guests: – Dr. Lisa Tarasenko, Obesity Global Medical Affairs Leader, Pfizer – Dr. Giles Yeo, Professor of Molecular Neuroendocrinology, University of Cambridge – Dr. David Cummings, Professor of Medicine, University of Washington, and Founding Director, Weight Management Clinic and Program, Seattle-Tacoma VA System Dive into the episode here: 00:00 – Wait, what is BMI? 02:58 – Why understanding obesity is crucial 05:05 – The problems with BMI 13:11 – A new definition of obesity Check out our YouTube channel (@Pfizer) to watch full interviews with Joe & special experts and guests for more on obesity. Season 7 of Science Will Win is created by Pfizer and hosted by Dr. Joe Hanson. It’s produced by Acast Creative Studios. Hosts in this podcast series were compensated for their time. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Why do we weigh what we weigh? The answer to that question is surprisingly complicated. On season seven of Pfizer's award-winning podcast Science Will Win, host Joe Hanson, a science storyteller and host of PBS’s Be Smart, explores the cutting-edge research that’s changing the way we think about hunger and weight. Understanding that research means diving into history, genetics, hormones, comorbidities, and real patient experiences. And, just like last season, you can find full length video discussions led by this season’s host on Pfizer’s YouTube channel. Season 7 of Science Will Win is coming soon—subscribe to stay tuned in! Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Cancer research is moving faster than ever—but too many patients never feel the impact of that progress. Artificial Intelligence (AI) is emerging as one tool that could help change that.
In the Season 6 finale of Science Will Win, Dr. Raven Baxter follows the human journey behind AI in oncology—from the moment of diagnosis to the real‑world barriers that determine access to care.
Along the way, we explore how thoughtfully designed artificial intelligence is reshaping trial design, enrollment, eligibility, and access—helping patients regain agency and bridging the gap between scientific breakthroughs and real‑world cancer care.
As the season concludes, one thing is clear: progress matters most when it reaches the people who need it.
Featured guests:
– Dr. Lionel Kankeu Fonkoua, Medical Oncologist and Translational Researcher, Mayo Clinic
– Jeff Legos, Chief Oncology Officer, Pfizer
– Dr. Ravi Parikh, Medical Oncologist; Director, Human‑Algorithm Collaboration Lab
– Maya R. Said, Founder and CEO, Outcomes4Me
Dive into the episode here:
00:00 – Past episodes introduce us to an emerging tech advancement
04:16 – What is a clinical trial?
07:35 – AI accelerating the pace of oncology
12:42 – Clinical trials and AI: How can it help?
16:17 – A gap between innovation and patient access
19:16 – Maya's story
23:47 – Clinical trials for AI tools
27:54 – Conclusion: building pathways alongside scientific innovation
Check out our YouTube channel (@Pfizer) to watch full interviews between Raven & some of the patients featured.
Season 6 of Science Will Win is created by Pfizer and hosted by Dr. Raven Baxter. It’s produced by Acast Creative Studios. Hosts in this podcast series were compensated for their time.
*The content in this episode is for informational purposes only and does not provide medical advice. Pfizer does not endorse or sponsor third‑party tools referenced. Patients should not use the tools described as a replacement for discussions with a healthcare provider. Patients should consult their healthcare provider regarding medical decisions. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
What comes after a cancer diagnosis and treatment?
In this episode of Science Will Win, host Dr. Raven Baxter explores one of the most important, and often overlooked, chapters for cancer patients: survivorship. As five-year survival rates climb to 70%, more people than ever are living with and beyond cancer. But longer survival brings its own complex challenges, and our care systems are still catching up.
You'll hear from experts and advocates working at the intersection of medicine, policy, and community. We’ll discuss what it really takes to support people through this transition — when the clinical benchmarks have passed and it’s time to go back to “normal life”.
From patient care plans and workplace disclosure to mental health, this episode makes one thing clear: survivorship demands dignity, support, and a whole new kind of care.
Featured guests:
– Tina Deignan, Commercial President, Pfizer Oncology
– Shelley Fuld Nasso, CEO, Cancer Nation
– Rebecca Nellis, Executive Director, Cancer and Careers
– Bob Riter, Breast Cancer Patient & Advocate
Dive into the episode here:
00:00 – The ongoing battle with cancer
03:43 – Rethinking survivorship
05:32 – The five-year survival myth
07:00 – The history of the term "survivor"
09:36 – Bob’s journey with breast cancer
11:38 – Lost in transition and survivorship care plans
14:25 – The intersection of cancer and work
18:49 – Rethinking how work gets done
20:00 – Disclosure and improving company culture
20:59 – The swivel technique
23:19 – Controlling your narrative
25:11 – Standardizing long-term survivorship care through policy
27:08 – Lack of access to care leads to disparities in survival rates
29:48 – Bob's second journey with cancer
32:21 – Takeaways and peek into our final episode
Check out our YouTube channel (@Pfizer) to watch the full interview with Raven & Bob Riter on his cancer journey.
Season 6 of Science Will Win is created by Pfizer and hosted by Dr. Raven Baxter. It’s produced by Acast Creative Studios. Hosts in this podcast series were compensated for their time. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.





